Chronic ethanol consumption is associated with changes in the function and structure of the lungs. The aim of this
study was to investigate the effect of chronic ethanol exposure on the lungs and whether ginger extract mitigated
pulmonary abnormalities induced by ethanol in rats. Male Wistar rats were divided into the control group, the ethanol
group, and the ethanol plus ginger extract group. Six weeks of ethanol treatment increased the proliferation of lung
cells, and induced fibrosis, inflammation and leukocyte infiltration. A significant rise in the level of 8-
hydroxydeoxyguanosine, NADPH oxidase, and oxidized low-density lipoprotein was also observed. Ginger extract
significantly ameliorated the above changes. These findings indicate that ethanol induces abnormalities in the lungs
by oxidative DNA damage and oxidative stress, and that these effects can be alleviated by ginger, which may function
as an antioxidant and anti-inflammatory agent.
Gumbarewicz E, Jarząb A, Stepulak A, et al. Zingiber officinale Rosc. in the Treatment of Metabolic Syndrome Disorders-A Review of In Vivo Studies. Int J Mol Sci, 2022, 23(24): 15545.
DOI:10.3390/ijms232415545
2.
Lieb B, Schmitt P. Randomised double-blind placebo-controlled intervention study on the nutritional efficacy of a food for special medical purposes (FSMP) and a dietary supplement in reducing the symptoms of veisalgia. BMJ Nutr Prev Health, 2020, 3(1): 31-39.
DOI:10.1136/bmjnph-2019-000042
3.
Thota SM, Balan V, Sivaramakrishnan V. Natural products as home-based prophylactic and symptom management agents in the setting of COVID-19. Phytother Res, 2020, 34(12): 3148-3167.
DOI:10.1002/ptr.6794
4.
Huang S, Huang Z, Fu Z, et al. A Novel Drug Delivery Carrier Comprised of Nimodipine Drug Solution and a Nanoemulsion: Preparation, Characterization, in vitro, and in vivo Studies. Int J Nanomedicine, 2020, 15: 1161-1172.
DOI:10.2147/IJN.S226591
5.
Mohd Sahardi NFN, Makpol S. Ginger (Zingiber officinale Roscoe) in the Prevention of Ageing and Degenerative Diseases: Review of Current Evidence. Evid Based Complement Alternat Med, 2019, 2019: 5054395.
DOI:10.1155/2019/5054395